Matt Holt at The Health Care Blog has a great primer for potential Big Pharma and Biotech whistleblowers.
"Here’s another piece of evidence to support my argument that whistleblowing represents the most promising career path for a young person starting out in the biomedical industry.
Biotechs such as Genentech, Amgen and the other large ones are an especially fertile venue. The avaricious ambitions of senior executives and their accompanying desire to mimic the Big Pharma operations tend to alienate both the scientists and the commercial people who were originally attracted to the biotech side of the drug discovery business. These increasingly disgruntled coworkers can provide excellent leads into illegal practices that the enterprising whistleblower can use to his/her advantage."
The Genentech whistleblower worked as a "medical science liason" (MSL) exec. This appears to be a job that is also a licence to print money for potential future whistleblowers.
Read all about it here:
The Healthcare Blog
No comments:
Post a Comment